Anna Garrido‐Utrilla

ORCID: 0000-0002-8074-6739
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic function and diabetes
  • Prostate Cancer Diagnosis and Treatment
  • Diabetes and associated disorders
  • Diabetes Management and Research
  • Adipose Tissue and Metabolism
  • Regulation of Appetite and Obesity
  • interferon and immune responses
  • RNA modifications and cancer
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • RNA Research and Splicing
  • Prostate Cancer Treatment and Research
  • MRI in cancer diagnosis

Institut de Biologie Valrose
2018-2022

Bellvitge University Hospital
2022

Institut Català d'Oncologia
2022

Institut d'Investigació Biomédica de Bellvitge
2022

Inserm
2018-2022

Université Côte d'Azur
2018-2022

Centre National de la Recherche Scientifique
2018-2022

Breast cancer risk for carriers of BRCA1 pathological variants is modified by genetic factors. Genetic variation in HMMR may contribute to this effect. However, the impact modifiers on biology remains undetermined and biological basis increased poorly understood. Here, we depict an interplay molecular, cellular, tissue microenvironment alterations that increase BRCA1-associated breast risk. Analysis genome-wide association results suggests diverse processes, including links BRCA1-HMMR...

10.1038/s41467-022-29335-z article EN cc-by Nature Communications 2022-04-07

Three-dimensional multiparametric ultrasound (3D mpUS) shows promise for accurately diagnosing prostate cancer. However, its technical complexity presents usability challenges. Human Factor Engineering (HFE) studies the interaction between devices and users, by reducing human error, increasing productivity, enhancing safety. The objective is to develop a training program 3D mpUS using HFE (NCT04605276). This study employs human-centered design approach, principle of HFE, with formative...

10.1080/17434440.2025.2473632 article EN cc-by-nc-nd Expert Review of Medical Devices 2025-03-04

Type 1 diabetes results from the autoimmune-mediated loss of insulin-producing beta-cells. Accordingly, important research efforts aim at regenerating these lost beta-cells by converting pre-existing endogenous cells. Following up on previous demonstrating conversion pancreatic somatostatin delta-cells into beta-like cells upon Pax4 misexpression and acknowledging that somatostatin-expressing are highly represented in gastrointestinal tract, one could wonder whether this -mediated also occur...

10.3389/fendo.2022.861922 article EN cc-by Frontiers in Endocrinology 2022-04-29

Background: Although several approaches have revealed much about individual factors that regulate pancreatic development, we yet to fully understand their complicated interplay during pancreas morphogenesis. Gfi1 is transcription factor specifically expressed in acinar cells, whose role cells fate identity and specification still elusive. Methods: In order gain further insight into the function of this pancreas, generated animals deficient for pancreas. conditional knockout were...

10.3390/cells10112805 article EN cc-by Cells 2021-10-20
Coming Soon ...